Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population

LESSONS LEARNED. Modification of FOLFIRINOX significantly improves safety and tolerability in Chinese patients with locally advanced pancreatic cancer. Patients with locally advanced pancreatic cancer benefit from neoadjuvant therapy and experience a much better survival than patients with upfront s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Li, Xiang, Guo, Chengxiang, Li, Qinghai, Wei, Shumei, Zhang, Qi, Chen, Yiwen, Shen, Yinan, Ma, Tao, Li, Guogang, Gao, Shunliang, Que, Risheng, Lou, Jianying, Yu, Risheng, Yuan, Ying, Wei, Qichun, Huang, Pintong, Liang, Tingbo, Bai, Xueli
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2018
Pynciau:
Clinical Trial Results
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519772/
https://ncbi.nlm.nih.gov/pubmed/30459238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0696
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg